Application 216484
- Type
- ANDA
- Sponsor
- ALKEM LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE | LIDOCAINE | PATCH;TOPICAL | 5% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216484-001 | LIDOCAINE | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216484-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216484-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A216484-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216484-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216484-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216484-001 | LIDOCAINE | 5% | PATCH / TOPICAL | AB | 2025-10-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216484-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A216484-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A216484-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216484-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216484-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MyDerm Aloe and Lidocaine | LIDOCAINE | Inspec Solutions LLC. | 4939c663-a876-4527-822a-df02964fa694 | 2026-05-26 | Warnings | LIDOCAINE |
| lidocaine | LIDOCAINE | Preferred Pharmaceuticals Inc. | 54df7353-5411-43ad-bd7b-a3d4d62c72c6 | 2026-05-21 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Preferred Pharmaceuticals Inc. | 4806f94d-cbac-4107-b93b-8f715868ffb3 | 2026-05-21 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Preferred Pharmaceuticals Inc. | ebc05cf9-e82b-4f7d-b5e7-3e62025ce68c | 2026-05-21 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Preferred Pharmaceuticals Inc. | 323e0ec2-c2e5-47d1-a39f-69ff5c99e324 | 2026-05-21 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine Pain Relief Patch | LIDOCAINE | GERI-CARE PHARMACEUTICAL CORP | 522f1521-f9f2-4c26-e063-6394a90a9e05 | 2026-05-19 | Warnings | LIDOCAINE |
| Burn Relief | LIDOCAINE | WALMART INC. | 15af4557-4baf-c177-e063-6294a90a7a5b | 2026-05-18 | Warnings | LIDOCAINE |
| LIDOCAINE PAIN RELIEF Gel-Patch | LIDOCAINE | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 01ff3442-5a4e-4013-e063-6294a90a809e | 2026-05-17 | Warnings | LIDOCAINE |
| LIDOCAINE PAIN RELIEF Gel-Patch | LIDOCAINE | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 247ecba5-196b-0179-e063-6394a90a0371 | 2026-05-17 | Warnings | LIDOCAINE |
| LIDOCAINE PAIN RELIEF Gel-Patch | LIDOCAINE | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 322aa97d-b35b-d9dd-e063-6394a90a7ae5 | 2026-05-17 | Warnings | LIDOCAINE |
| KY Duration for Him | LIDOCAINE | Reckitt Benckiser LLC | 83cc86bd-3303-4956-a198-fae85b6e34e1 | 2026-05-15 | Warnings | LIDOCAINE |
| Lidocaine Knee Pain Relief Patch | LIDOCAINE | Guangzhou Sumi Technology Innovation Co., Ltd | 4fdbc841-ee84-c1b3-e063-6294a90a6f5c | 2026-05-14 | Warnings | LIDOCAINE |
| Lidocaine Pain Relief Gel -Patch | LIDOCAINE | Guangzhou Sumi Technology Innovation Co., Ltd | 514900f1-7fcb-636a-e063-6394a90a4ba2 | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relief Gel-Roll On | LIDOCAINE | Trifecta Pharmaceuticals USA | 51cb6797-55ec-7a7a-e063-6294a90a90ee | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relieving Gel-Patch | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 412fd7c8-1e05-1779-e063-6294a90a3de4 | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relief | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 433ac435-279e-574b-e063-6294a90a1d6d | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relief | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 3ef5bfac-0c05-b703-e063-6394a90a2276 | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relieving Gel-Patch | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 3737cd00-0582-94e6-e063-6394a90a6280 | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relieving Gel-Patch | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | f1045448-ae78-eba6-e053-2a95a90a6793 | 2026-05-14 | Warnings | LIDOCAINE |
| Pain Relieving Gel-Patch | LIDOCAINE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | fd0d4646-4b5e-3fe8-e053-6394a90ad6c4 | 2026-05-14 | Warnings | LIDOCAINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.